Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 7169791 Inhibitors of tyrosine kinases

Patent 7169791 was granted and assigned to Novartis on January, 2007 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Current Assignee

Novartis

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

71697910

Patent Inventor Names

Pascal Furet0

Paul William Manley0

Sandra Jacob0

Werner Breitenstein0

Date of Patent

January 30, 2007

Patent Application Number

105203590

Date Filed

July 4, 2003

Patent Citations Received

‌

US Patent 12016861 Amorphous nilotinib microparticles and uses thereof

‌

US Patent 12064428 Kinase inhibitor salts and compositions thereof

‌

US Patent 12064430 Kinase inhibitor salts and compositions thereof

‌

US Patent 11708412 Methods for treating hematologic cancers

‌

US Patent 11998548 Amorphous nilotinib microparticles and uses thereof

‌

US Patent 11827704 Antibody molecules to PD-1 and uses thereof

Patent Primary Examiner

‌

Deepak Rao

Patent abstract

The invention relates to compounds of formula

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 7169791 Inhibitors of tyrosine kinases

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API